Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Illumina (GB:0J8Z)
LSE:0J8Z
Illumina (0J8Z) Share Price & Analysis
0 Followers
0J8Z Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$89.21 - $229.07
Previous Close$121
Volume376.00
Average Volume (3M)6.38K
Market Cap
$19.11B
Enterprise Value$21.28B
Total Cash (Recent Filing)$6.00M
Total Debt (Recent Filing)$2.18B
Price to Earnings (P/E)-16.5
Beta1.23
Next Earnings
May 02, 2024EPS Estimate
$0.04Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.34
Shares Outstanding158,900,000
10 Day Avg. Volume1,382
30 Day Avg. Volume6,384
Standard Deviation0.10
R-Squared0.14
Alpha0.02
Financial Highlights & Ratios
Price to Book (P/B)90.14
Price to Sales (P/S)15.90
Price to Cash Flow (P/CF)20.80
P/FCF Ratio23.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.72
Enterprise Value/Gross Profit7.75
Enterprise Value/Ebitda-276.33
Forecast
1Y Price Target
$151.18Price Target Upside24.94% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering13
Illumina News
PremiumCompany Announcements
Illumina Gains Approval for GRAIL Divestiture Plans
PremiumCompany Announcements
Illumina Announces Executive Shift and New CFO Appointment
Bulls Say, Bears Say
Bulls Say
Market ExpansionClinical markets remain underpenetrated, presenting a growth opportunity for companies like ILMN with evolving sequencing applications.
Regulatory ApprovalThe EU approved ILMN's divestiture plan, providing a clear path forward.
Strategic FlexibilityILMN retains the flexibility to pursue a third-party sale or a spin-off, providing multiple strategic options.
Bears Say
Financial GuidanceBacklog at the end of FY23 is now down to $653mn, sharply lower compared to FY22 ending backlog.
Management StabilityILMN has seen the departure of multiple top executives in the past year, which raises concerns about corporate stability.
Regulatory ChallengesThe European Commission had previously prohibited the transaction between ILMN and GRAIL and proposed a substantial fine, indicating challenges in the merger process.
---
Options Prices
Currently, No data available
---
Ownership Overview
1.81% Insiders
30.84% Mutual Funds
29.19% Other Institutional Investors
38.16% Public Companies and
Individual Investors
0J8Z FAQ
What was Illumina’s price range in the past 12 months?
Illumina lowest share price was $89.21 and its highest was $229.07 in the past 12 months.
What is Illumina’s market cap?
Currently, no data Available
When is Illumina’s upcoming earnings report date?
Illumina’s upcoming earnings report date is May 02, 2024 which is in 9 days.
How were Illumina’s earnings last quarter?
Illumina released its earnings results on Feb 08, 2024. The company reported $0.14 earnings per share for the quarter, beating the consensus estimate of $0.019 by $0.121.
Is Illumina overvalued?
According to Wall Street analysts Illumina’s price is currently Undervalued.
Does Illumina pay dividends?
Illumina does not currently pay dividends.
What is Illumina’s EPS estimate?
Illumina’s EPS estimate is $0.04.
How many shares outstanding does Illumina have?
Illumina has 158,900,000 shares outstanding.
What happened to Illumina’s price movement after its last earnings report?
Illumina reported an EPS of $0.14 in its last earnings report, beating expectations of $0.019. Following the earnings report the stock price went down -4.38%.
Which hedge fund is a major shareholder of Illumina?
Among the largest hedge funds holding Illumina’s share is Guardcap Asset Management Ltd. It holds Illumina’s shares valued at 285M.
---
Illumina Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$151.18 (24.94% Upside)
$151.18 (24.94% Upside)
Blogger Sentiment
Bullish
GB:0J8Z Sentiment 78%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $991.7K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-47.18%
12-Months-Change
Fundamentals
Return on Equity
-18.81%
Trailing 12-Months
Asset Growth
-17.47%
Trailing 12-Months
Company Description
Illumina
Incorporated in 1998, Illumina, Inc. is a California-based company which develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. Its products and services serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company's products include microarray scanners, sequencing reagents, and onsite training selector. Its services include sequencing and microarray services; proactive instrument monitoring; and instrument services, training, and consulting.
---
0J8Z Company Deck
---
0J8Z Earnings Call
Q4 2024
0:00 / 0:00
---
0J8Z Revenue Breakdown
68.45% Consumables
15.92% Service and other revenue
15.63% Instruments
---
0J8Z Stock 12 Months Forecast
Average Price Target
$151.18
▲(24.94% Upside)
Technical Analysis
Best Analysts Covering 0J8Z
1 Year
1 Year Success Rate
16/20 ratings generated profit
1 Year Average Return
+15.39%
reiterated a sell rating 14 days ago
Copying Luke Sergott's trades and holding each position for 1 Year would result in 80.00% of your transactions generating a profit, with an average return of +15.39% per trade.
---